Neuroscouting LLC

Transgene Inc., based in Cambridge, MA, is a biotechnology company specializing in the development of viral-based immunotherapies for cancer treatment. Their innovative approaches include individualized neoantigen cancer vaccines, shared antigen cancer vaccines, and oncolytic viruses, aiming to enhance the immune response against tumors. The company's product pipeline features several clinical trials, such as TG4050, TG4001, and TG6050, all designed to leverage personalized medicine in combating various forms of cancer. Through its advanced platforms, including myvac and Invir.IO, Transgene seeks to revolutionize cancer therapy by tailoring treatments to individual patient profiles. Generated from the website